NCT07509151
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07509151
Title Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV) (SOUNDTRACK-C1)
Acronym SOUNDTRACK-C1
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult
Covered Countries TUR | GBR | CAN | AUS

Facility Status City State Zip Country Details
Research Site Adelaide 5000 Australia Details
Research Site Fitzroy 3065 Australia Details
Research Site Nedlands 6009 Australia Details
Research Site Calgary Alberta T2N 5G2 Canada Details
Research Site Hamilton Ontario L8V 5C2 Canada Details
Research Site Montreal Quebec H3T 1E2 Canada Details
Research Site Istanbul 34899 Turkey (Türkiye) Details
Research Site Mezitli 33200 Turkey (Türkiye) Details
Research Site Edinburgh EH4 2XU United Kingdom Details
Research Site Leeds LS9 7TF United Kingdom Details
Research Site London SE5 9RS United Kingdom Details
Research Site Oxford OX3 7LE United Kingdom Details
Research Site Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field